Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04972513 · ClinicalTrials.gov registry record
Impact of E-cigarette Use on the Body
A clinical trial of Cigarette Smoking-Related Carcinoma, sponsored by Ohio State University Comprehensive Cancer Center.
- Active
- Registry status
- 182
- Enrollment target
- 1
- Study location
NCT04972513: Active study of Cigarette Smoking-Related Carcinoma, sponsored by Ohio State University Comprehensive Cancer Center.
NCT04972513 is a study of Cigarette Smoking-Related Carcinoma that is active but no longer recruiting, run by Ohio State University Comprehensive Cancer Center. The registered enrollment target is 182 participants, below the 459-participant average among 21 other Cigarette Smoking-Related Carcinoma trials with a reported enrollment target (60% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04972513, a study of Cigarette Smoking-Related Carcinoma, is active but no longer recruiting, sponsored by Ohio State University Comprehensive Cancer Center.
- ACTIVE NOT RECRUITING
- Registry status
- 182 participants
- Enrollment target
- 1
- Study location
Study Summary
This study examines how electronic (e)-cigarette use impacts the body, by studying both users and non-users of e-cigarettes. Early evidence indicates that e-cig users experience adverse health effects. Results of this study may help policy-makers develop standards for different types of tobacco.
Primary Outcome
Exhaled nitric oxide will be measured in parts per billion (ppb)
Conditions Studied
Interventions
- PROCEDURE Biospecimen Collection
- OTHER Survey Administration
- PROCEDURE Nitric Oxide Breath Test
- PROCEDURE Oscillometry
- PROCEDURE Spirometry
Study Locations (1)
Ohio
- Ohio State University Comprehensive Cancer Center - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 182 participants |
| Start Date | 2021-07-22 |
| Est. Completion | 2026-12-31 |
What the registry record for NCT04972513 still lists
NCT04972513 is an observational study that tracks outcomes without assigning an intervention. The registered 182 participants enrollment target is mid-sized for trials with a published cap, below the 459-participant average among 21 other Cigarette Smoking-Related Carcinoma trials with a reported enrollment target (60% lower).
The record links to 1 condition, with Cigarette Smoking-Related Carcinoma appearing as the primary indexed condition, and to 5 interventions - of which Biospecimen Collection is the first listed.
NCT04972513 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT04972513 about?
NCT04972513 is a clinical study titled "Impact of E-cigarette Use on the Body". This study examines how electronic (e)-cigarette use impacts the body, by studying both users and non-users of e-cigarettes. Early evidence indicates that e-cig users experience adverse health effects. Results of this study may help policy-makers develop standards for different types of tobacco.
What is the current status of trial NCT04972513?
This trial is currently active not recruiting. The enrollment target is 182 participants. The study started on 2021-07-22. Estimated completion is 2026-12-31.
What conditions does trial NCT04972513 study?
This clinical trial studies the following conditions: Cigarette Smoking-Related Carcinoma.
What interventions are being tested in trial NCT04972513?
The interventions under investigation include: Biospecimen Collection (PROCEDURE), Survey Administration (OTHER), Nitric Oxide Breath Test (PROCEDURE), Oscillometry (PROCEDURE), Spirometry (PROCEDURE).
Who is sponsoring clinical trial NCT04972513?
This trial is sponsored by Ohio State University Comprehensive Cancer Center, which has 341 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04972513 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cigarette Smoking-Related Carcinoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04972513's enrollment target sits among peer trials
182 10th of 21 higher than 11 of 21 other Cigarette Smoking-Related Carcinoma trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cigarette Smoking-Related Carcinoma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Digital Smoking Cessation Intervention for Helping American Indians and Alaska Natives Quit Smoking, IndigeQuit Trial
RECRUITING · NA
-
Carcinogen and Toxicant Exposure Among Young Adults Who Co-Use E-cigarettes and Cannabis (Co-Tox Study)
RECRUITING
-
Sensory Tests of Cigarettes for Identification of Flavors in Current Daily Smoking Adults
RECRUITING · Early Phase 1
-
Nicotine Replacement Therapy, Counseling, Varenicline, and Bupropion for Smoking Cessation, the PISCES I Trial
RECRUITING · Phase 4
-
Testing the Effect of the Broccoli Seed and Sprout Extract, Avmacol ES, on the Cancer Causing Substances of Tobacco in Heavy Smokers
RECRUITING · Phase 2
-
CONNECTing to LungCare
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03897998 · 182 participants · Phase 2
Neural Correlates of Hypoalgesia Driven by Observation
- NCT04300556 · 182 participants · Phase 1
A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin), a Folate Receptor Alpha (FRα)-Targeting Antibody-drug Conjugate (ADC) in Participants With Selected Tumor Types
- NCT04323735 · 182 participants · Phase 2
Intravesical Lactobacillus for Urinary Symptoms Among People With NLUTD Who Use Indwelling Catheters
- NCT05606731 · 182 participants · NA
Family Intervention to Prevent Childhood Obesity
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI